SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Infectious Disease Research Institute (IDRI) and PATH Enter into Research Collaboration Agreement to Evaluate Novel Adjuvants to Enhance Pandemic Influenza Vaccines